EMA moving to Amsterdam – congratulations
The race for the new EU medicines authority is over and a decision has been made: Amsterdam will be the new site of the European Medicines Agency (EMA). The Paul-Ehrlich-Institut (PEI) sends its best wishes to the Netherlands and its congratulations for this special success.
PEI expert for vaccines and biomedicines elected as member of the EMA's Committee for Medicinal Products for Human Use
The Committee for Medicinal Products for Human Use at the European Medicines Agency assesses new medicinal products and gives recommendations in favour of or against European marketing authorisations to the European Commission. Dr Jan Müller-Berghaus, expert for vaccines and biomedicines at the Paul-Ehrlich-Institut (PEI) renewed his candidacy for membership at the CHMP which was confirmed as per 9 November 2017 for another three years.
Safe blood products – PEI develops WHO-reference materials for platelet concentrates
Testing of blood products for pathogenic agents is an important pillar of blood product safety. Researchers of the Paul-Ehrlich-Institut (PEI) have extended the repository of reference strains for the testing of platelet concentrates as part of their role as Collaborating Centre for the World Health Organization by ten bacterial strains.